← Back
Data updated: Mar 10, 2026
BAJAJ
Pharmaceuticals
BAJAJ is a generic drug manufacturer with 6 FDA-approved products.
1997
Since
6
Drugs
-
Trials
46
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF 2025-11-25
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
CETIRIZINE HYDROCHLORIDE 2025-08-29
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-08-13
Labeling
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY 2025-08-01
Labeling
CETIRIZINE HYDROCHLORIDE 2025-07-17
Labeling
CETIRIZINE HYDROCHLORIDE 2025-07-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (4)
Company Info
- First Approval
- 1997-09-11
- Latest
- 2025-11-25
- Applications
- 6